Table 2 Baseline data from validation set
Level | Short (n = 42) | Long (n = 40) | p | |
|---|---|---|---|---|
Age | 62.48 ± 8.70 | 63.40 ± 9.07 | 0.639 | |
Gender (%) | 0 | 15 (35.7) | 17 (42.5) | 0.687 |
1 | 27 (64.3) | 23 (57.5) | ||
Disease1 (%) | 0 | 41 (97.6) | 30 (75.0) | 0.007 |
1 | 1 (2.4) | 10 (25.0) | ||
Disease2 (%) | 0 | 37 (88.1) | 36 (90.0) | 1.000 |
1 | 5 (11.9) | 4 (10.0) | ||
Smoking (%) | 0 | 25 (59.5) | 20 (50.0) | 0.519 |
1 | 17 (40.5) | 20 (50.0) | ||
Lobe (%) | 1 | 9 (21.4) | 5 (12.5) | 0.047 |
2 | 6 (14.3) | 1 (2.5) | ||
3 | 14 (33.3) | 24 (60.0) | ||
4 | 1 (2.4) | 3 (7.5) | ||
5 | 12 (28.6) | 7 (17.5) | ||
Calcification (%) | 0 | 37 (88.1) | 8 (20.0) | < 0.001 |
1 | 5 (11.9) | 32 (80.0) | ||
Height | 167.57 ± 7.52 | 166.52 ± 10.04 | 0.594 | |
Weight | 70.60 ± 8.45 | 72.47 ± 12.01 | 0.413 | |
FVC/Pred FVC | 97.72 ± 13.52 | 95.35 ± 14.40 | 0.445 | |
FEV1/predFEV1 | 95.85 ± 15.49 | 87.05 ± 16.87 | 0.016 | |
FEV1/FVC | 81.06 ± 7.14 | 73.65 ± 9.94 | < 0.001 | |
DLCO.SB | 87.34 (15.08 | 86.52 ± 11.24 | 0.783 | |
White blood cell | 5.94 ± 1.35 | 6.93 ± 2.17 | 0.015 | |
Absolute neutrophil count | 3.80 ± 1.10 | 4.44 ± 2.16 | 0.093 | |
Red blood cell | 4.47 ± 0.53 | 4.48 ± 0.41 | 0.915 | |
Hemoglobin | 136.93 ± 14.32 | 138.38 ± 13.22 | 0.636 | |
Prothrombin time | 13.10 ± 0.95 | 12.96 ± 0.60 | 0.405 | |
Activated partial thromboplastin time | 36.82 ± 3.05 | 35.93 ± 3.17 | 0.200 | |
Thrombin time | 16.88 ± 1.18 | 16.91 ± 1.18 | 0.897 | |
D. dimer | 0.37 ± 0.37 | 0.53 ± 0.99 | 0.337 | |
Albumin | 42.95 ± 4.85 | 44.28 ± 3.58 | 0.165 | |
Creatinine | 71.52 ± 12.22 | 71.53 ± 15.70 | 1.000 | |